Skip to main content
SpringerLink
Log in

Molecular Imaging in Oncology

  • Chapter
Molecular Nuclear Medicine

  • 260 Accesses

Abstract

A first draft of the human genome has been completed (Pennisi 2000) and, while much work remains to complete a refined map, this accomplishment is expected to lead to new medical treatments, drugs, and ultimately cures previously thought impossible. In this emerging “post-genomic era”, wherein functionality will be added to this vast array of genetic information, opportunity exists for imaging to play a significant role in both basic and translational research as related to functional genomics. Herein, the overall objective is focused on adding function through molecular imaging. Molecular imaging is broadly defined as the characterization and measurement of biological processes in living animals, model systems and humans at the cellular and molecular level using remote imaging detectors. The goal is to advance our understanding of biology and medicine through noninvasive in vivo investigation of cellular and molecular events involved in normal and pathologic processes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allikmets R, Schrimi L, Hutchinson A et al (1998) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337–5339

    PubMed  Google Scholar 

  • Aloj L, Caraco C, Jagoda E et al (1999) Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res 59:4709–4714

    PubMed  Google Scholar 

  • Anderson CJ, Lewis JS (2000) Radiopharmaceuticals for targeted radiotherapy of cancer. Exp Opin Ther Patents 10:1057–1069

    Google Scholar 

  • Anderson CJ, Pajeau T, Edwards W et al (1995) In vitro and in vivo evaluation of copper-64-octreotide conjugates. J Nucl Med 36:2315–2325

    PubMed  Google Scholar 

  • Anderson CJ, Jones LA, Bass LA et al (1998) Radiotherapy, toxicity and dosimetry of copper-64-TETA-Octreotide in tumor-bearing rats. J Nucl Med 39:1944–1951

    PubMed  Google Scholar 

  • Anderson CJ, Dehdashti F, Cutler PD et al (2001) Copper-64-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 42:213–221

    PubMed  Google Scholar 

  • Bakker WH, Albert R, Bruns C et al (1991a) [111In-DTPA-D-Phe]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49:1583–1591

    PubMed  Google Scholar 

  • Bakker WH, Krenning EP, Reubi JC et al (1991b) In vivo application of [In-lll-DTPA-D-Phe]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 49:1593–1601

    PubMed  Google Scholar 

  • Ballinger J, Hua H, Berry B et al (1995 a) 99mTc-Sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 16:253–257

    PubMed  Google Scholar 

  • Ballinger JR, Sheldon KM, Boxen I et al (1995b) Differences between accumulation of 99mTc-MIBI and Tl-201-thallous chloride in tumor cells: role of P-glycoprotein. Q J Nucl Med 39:122–128

    PubMed  Google Scholar 

  • Ballinger JR, Bannerman J, Boxen I et al (1996) Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 37:1578–1582

    PubMed  Google Scholar 

  • Ballinger JR, Muzzammil T, Moore M (1997) Technetium-99m-Furifosmin as an agent for functional imaging of multidrug resistance in tumors. J Nucl Med 38:1915–1919

    PubMed  Google Scholar 

  • Bangard M, Behe M, Guhlke S et al (2000) Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide. Eur J Nucl Med 27:628–637

    PubMed  Google Scholar 

  • Barbaries E, Kronauge J, Cohen D et al (1998) Characterization of P-glycoprotein transport and inhibition in vivo. Cancer Res 58:276–282

    Google Scholar 

  • Bauer W, Briner U, Doepfner W et al (1982) SMS 201-995. Life Sci 31:1133–1140

    PubMed  Google Scholar 

  • Beyer T, Townsend D, Brun T et al (2000) Combined PET/ CT scanner for clinical oncology. J Nucl Med 41:1369–1379

    PubMed  Google Scholar 

  • Blasberg R, Tjuvajev J (1999) Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. Q J Nucl Med 43:163–169

    PubMed  Google Scholar 

  • Bohuslavizki KH, Brenner W, Braunsdorf WEK et al (1996) Somatostatin receptor scintigraphy in the differential diagnosis of meningioma. Nucl Med Commun 17:302–310

    PubMed  Google Scholar 

  • Boland A, Ricard M, Opolon P et al (2000) Adenovirusmediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 60:3484–3492

    PubMed  Google Scholar 

  • Bom H, Kim Y, Lim S et al (1997) Dipyridamole modulated Tc-99m-Tc-sestamibi (mibi) scintigraphy: a predictor of response to chemotherapy in patients with small cell lung cancer. J Nucl Med 38:240P

    Google Scholar 

  • Bosch I, Croop J (1996) P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1288:F37–F54

    PubMed  Google Scholar 

  • Brockmann J, Rosch F, Herzog H et al (1995) In vivo uptake kinetics and dosimetry calculations of 86Y-DTPA-octreotide with PET as a model for potential endotherapeutic octreotides labelled with 90Y. J Labelled Compounds Radiopharm 37:519–521

    Google Scholar 

  • Brosius FR, Nguyen N, Egert S et al (1997) Increased sarcolemmal glucose transporter abundance in myocardial ischemia. Am J Cardiol 80:77A–84A

    PubMed  Google Scholar 

  • Brown R, Wahl R (1993) Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72:2979–2985

    PubMed  Google Scholar 

  • Brown R, Leung J, Fisher S (1996) Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med 37:1042–1047

    PubMed  Google Scholar 

  • Buchsbaum DJ, Rogers BE, Khazaeli MB et al (1999) Targeting strategies for cancer radiotherapy. Clin Cancer Res 5 [Suppl]:3048s-3055s

    Google Scholar 

  • Carrasco N (1993) Iodide transport in the thyroid gland. Biochim Biophys Acta 1154:65–82

    PubMed  Google Scholar 

  • Charziioannou A, Cherry S, Shao Y et al (1999) Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med 40:1164–1175

    Google Scholar 

  • Chen C, Meadows B, Regis J et al (1997) Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m-Tc-Sestamibi. Clin Cancer Res 3:545–552

    PubMed  Google Scholar 

  • Chen W, Luker K, Dahlheimer J et al (2000) Effects of MDR1 and MDR3 P-glycoproteins, MRP1 and BCRP/ MXR/ABCP on transport of Tc-99m-Tc-tetrofosmin. Biochem Pharmacol 60:413–426

    PubMed  Google Scholar 

  • Ciarmiello A, Del Vecchio S, Silvestro P et al (1998) Tumor clearance of technetium-99m-Sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 16:1677–1683

    PubMed  Google Scholar 

  • Clavo A, Brown R, Wahl R (1995) 2-Fluoro-2-deoxy-D-glucose (FDG) uptake into human cancer cell lines is increased by hypoxia. J Nucl Med 36:1625–1632

    PubMed  Google Scholar 

  • Cole SPC, Bhardwaj G, Gerlach JH et al (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650–1654

    PubMed  Google Scholar 

  • Cordobes M, Starzec A, Delmon-Moingeon L et al (1996) Technetium-99m-Sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 37:286–289

    PubMed  Google Scholar 

  • Crankshaw C, Piwnica-Worms D (1996) Tc-99m-Tc-Sestamibi may be a transport substrate of the human multidrug resistance-associated protein (MRP). J Nucl Med 37:247P

    Google Scholar 

  • Crankshaw C, Marmion M, Luker G et al (1998) Novel Tc(III)-Q-complexes for functional imaging of the multidrug resistance (MDR1) P-glycoprotein. J Nucl Med 39:77–86

    PubMed  Google Scholar 

  • Dantzig A, Shepard R, Cao J et al (1996) Reversal of P-gly-coprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 56:4171–4179

    PubMed  Google Scholar 

  • Decristoforo C, Melendez-Alafort L, Sosabowski JK et al (2000) 99mTc-HYNIC-Tyr’-Octreotide for imaging soma-tostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. J Nucl Med 41:1114–1119

    PubMed  Google Scholar 

  • Dehdashti F, Flanagan F, Mortimer J et al (1999) Positron emission tomographic assessment of “metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med 26:51–56

    PubMed  Google Scholar 

  • De Jong M, Breeman WAP, Bernard BF et al (2001) [177Lu-DOTA0-Tyr3]Octreotate for somatostatin receptor-targeted radionuclide therapy. Int J Cancer 92:628–633

    PubMed  Google Scholar 

  • Del Vecchio S, Ciarmiello A, Pace L et al (1997 a) Fractional retention of technetium-99m-sestamibi as an index of Pglycoprotein expression in untreated breast cancer patients. J Nucl Med 38:1348–1351

    PubMed  Google Scholar 

  • Del Vecchio S, Ciarmiello A, Potena MI et al (1997 b) In vivo detection of multidrug resistance (MDR1) phenotype by technetium-99m-sestamibi scan in untreated breast cancer patients. Eur J Nucl Med 24:150–159

    PubMed  Google Scholar 

  • Derossi D, Calvet S, Trembleau A et al (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271:18188–18193

    PubMed  Google Scholar 

  • Doyle L, Yang W, Abruzzo L et al (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665–15670

    PubMed  Google Scholar 

  • Elliot G, O’Hare P (1997) Intercellular trafficking and protein delivery by a Herpes virus structural protein. Cell 88:223–233

    Google Scholar 

  • Fawell S, Seery J, Daikh Y et al (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91:664–668

    PubMed  Google Scholar 

  • Flens MJ, Zaman GJR, Valk P van der et al (1996) Tissue distribution of multidrug resistance protein. Am J Pathol 148:1237–1247

    PubMed  Google Scholar 

  • Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155–199

    PubMed  Google Scholar 

  • Frankel A, Pabo C (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189–1193

    PubMed  Google Scholar 

  • Fukumoto M, Yoshida D, Hayase N et al (1999) Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study. Cancer 86:1470–1479

    PubMed  Google Scholar 

  • Gambhir S, Barrio J, Herschman H et al (1999 a) Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol 26:481–490

    PubMed  Google Scholar 

  • Gambhir S, Barrio J, Phelps M et al (1999b) Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 96:2333–2338

    PubMed  Google Scholar 

  • Gambhir S, Bauer E, Black M et al (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 97:2785–2790

    PubMed  Google Scholar 

  • Gaveriaux C, Boesch D, Jachez B (1991) PSC 833 a non-immunosuppressive cyclosporin analog, is a very potent multidrug-resistance modifier. J Cell Pharmacol 2:225–234

    Google Scholar 

  • Germann U, Ford P, Schlakhter D et al (1997) Chemosensiti-zation and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209, and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Anticancer Drugs 8:141–155

    PubMed  Google Scholar 

  • Giaccone G, van Ark-Otte J, Rubio G et al (1996) MRP is frequently expressed in human lung cancer cell lines, in non-small cell lung cancer and in normal lungs. Int J Cancer 66:760–767

    PubMed  Google Scholar 

  • Golshani-Hebroni S, Bessman S (1997) Hexokinase binding to mitochondria: a basis for proliferative energy metabolism. J Bioenerget Biomembr 29:331–338

    Google Scholar 

  • Gottesman M, Pastan MI (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427

    PubMed  Google Scholar 

  • Gros P, Ben Neriah Y, Croop JM et al (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728–731

    PubMed  Google Scholar 

  • Guhlke S, Wester H-J, Bruns C et al (1994) (2-[18F]Fluoropropionyl-D(phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl Med Biol 21:819–825

    PubMed  Google Scholar 

  • Guillemin R (1978) Peptides in the brain: the new endocrinology of the neuron. Science 202:390–402

    PubMed  Google Scholar 

  • Haberkorn U, Oberdorfer F, Gebert J et al (1996) Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J Nucl Med 37:87–94

    PubMed  Google Scholar 

  • Hanania E, Fu S, Roninson I et al (1995) Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther 2:279–284

    PubMed  Google Scholar 

  • Haubner R, Avril N, Hantzopoulos P et al (2000) In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. Eur J Nucl Med 27:283–291

    PubMed  Google Scholar 

  • Hendrikse N, Franssen E, van der Graaf W et al (1998) 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer 77:353–358

    PubMed  Google Scholar 

  • Hendrikse N, Franssen E, van der Graaf W et al (1999) Visualization of multidrug resistance in vivo. Eur J Nucl Med 26:283–293

    PubMed  Google Scholar 

  • Henze M, Schuhmacher J, Hipp P et al (2001) PET imaging of somatostatin receptors using [68Ga]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. Nucl Med 42:1053–1056

    Google Scholar 

  • Herman LW, Sharma V, Kronauge JF et al (1995) Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. J Med Chem 38:2955–2963

    PubMed  Google Scholar 

  • Herschman H, Barrio J, Satyamurthy N et al (2000) Progress toward in vivo imaging of reporter gene expression using positron emission tomography. Am Soc Clin Oncol Educ Book Spring 169–177

    Google Scholar 

  • Higashi K, Clavo A, Wahl R (1993) Does FDG uptake measure the proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and 3H-thymidine uptake. J Nucl Med 34:414–419

    PubMed  Google Scholar 

  • Hoekstra C, Paglianiti I, Hoekstra O et al (2000) Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med 27:731–743

    PubMed  Google Scholar 

  • Hospers G, Calogero A, van Waarde A et al (2000) Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography. Cancer Res 60:1488–1491

    PubMed  Google Scholar 

  • Hyafil F, Vergely C, Du Vignaud P et al (1993) In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res 53:4595–4602

    PubMed  Google Scholar 

  • Josephson L, Tung C-H, Moore A et al (1999) High-efficiency intracellular magnetic labeling with novel super-paramagnetic-Tat peptide conjugates. Bioconjug Chem 10:186–191

    PubMed  Google Scholar 

  • Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162

    PubMed  Google Scholar 

  • Keppler D, Leier I, Jedlitschky G (1997) Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787–791

    PubMed  Google Scholar 

  • Klepper J, Fischbarg J, Vera J et al (1999) Glut 1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr es 46:677–683

    Google Scholar 

  • Kostakoglu L, Elahi N, Kirarli P et al (1994) Clinical validation of the influence of P-glycoprotein on technetium-99m-Sestamibi uptake in malignant tumors. J Nucl Med 38:1003–1008

    Google Scholar 

  • Kostakoglu L, Kirath P, Ruacan S et al (1998) Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med 39:228–234

    PubMed  Google Scholar 

  • Krenning EP, Bakker WH, Kooij PPM et al (1992) Somatostatin receptor scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in man: metabolism, dosimetry and comparison with Iodine-123-Tyr-3-Octreotide. J Nucl Med 33:652–658

    PubMed  Google Scholar 

  • Krenning EP, Kwekkeboom D, Bakker W et al (1993) Soma-tostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I123-Tyr]octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731

    PubMed  Google Scholar 

  • Krenning EP, Kooij PPM, Bakker WH et al (1994) Radiotherapy with a radiolabeled somatostatin analogue, 111In-DTPA-Phel-Octreotide: a case history. Ann NY Acad Sci 733:496–506

    PubMed  Google Scholar 

  • Krenning EP, de Jong M, Kooij PPM et al (1999) Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol 10 [Suppl 2]:S23–S29

    PubMed  Google Scholar 

  • Kubota S, Siomi H, Satoh T et al (1989) Functional similarity of HIV-1 rev and HTLV-1 rex proteins: identification of a new nucleolar-targeting signal in rev protein. Biochem Biophys Res Commun 162:963–970

    PubMed  Google Scholar 

  • Kubota K, Kubota R, Yamada S (1993) FDG accumulation in tumor tissue. J Nucl Med 34:419–421

    PubMed  Google Scholar 

  • Kwekkeboom DJ, Kam BL, Bakker WH et al (2001) Treatment with 177Lu-DOTA0-Tyr3-octreotate in patients with somatostatin receptor positive tumors: preliminary results (abstract). J Nucl Med 42:37P

    Google Scholar 

  • Larson S, Grunbaum Z, Rasey J (1980) Positron imaging feasibility studies: selective tumor concentration of 3H-thymidine, 3H-uridine, and 14C-2-deoxyglucose. Radiology 134:771–773

    PubMed  Google Scholar 

  • Lautier D, Canitrot Y, Deeley R et al (1996) Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 52:967–977

    PubMed  Google Scholar 

  • Lewis JS, Lewis MR, Cutler PD et al (1999) Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-Octreotate in a somatostatin receptor-positive tumor-bearing rat model. Clin Cancer Res 5:3608–3616

    PubMed  Google Scholar 

  • Lewis JS, Wang M, Laforest R et al (2002) Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model. Int J Cancer (in press)

    Google Scholar 

  • Lim S-C, Park K-O, Kim Y-C et al (2000) Comparison of Tc-99m Sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer. Cancer Biother Radiopharm 15:381–386

    PubMed  Google Scholar 

  • Liu S, Edwards D (1999) 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem Rev 99:2235–2268

    PubMed  Google Scholar 

  • Luker G, Rao V, Crankshaw C et al (1997 a) Characterization of phosphine complexes of technetium (III) as transport substrates of the multidrug resistance (MDR1) P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Biochemistry 36:14218–14227

    PubMed  Google Scholar 

  • Luker GD, Fracasso PM, Dobkin J et al (1997 b) Modulation of the multidrug resistance P-glycoprotein: detection with Tc-99m-Tc-Sestamibi in vivo. J Nucl Med 38:369–372

    PubMed  Google Scholar 

  • Maclaren D, Gambhir S, Satyamurthy N et al (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785–791

    PubMed  Google Scholar 

  • Maisey M, Wahl R, Barrington S (1999) Atlas of clinical positron emission tomography. Arnold, Oxford University Press, London, ISBN 0-340-740981

    Google Scholar 

  • Marshall B, Hansen P, Ensor N et al (1999) Glut-1 or Glut-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance. Am J Physiol 276:E390–E400

    PubMed  Google Scholar 

  • Marshall M, Neal F, Goldberg DM (1979) Isoenzymes of hexokinase, 6-phosphogluconate dehydrogenase, phos-phoglucomutase and lactate dehydrogenase in uterine cancer. Br J Cancer 40:380–390

    PubMed  Google Scholar 

  • Mathupala S, Rempel A, Pedersen P (1997) Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerget Biomembr 29:339–343

    Google Scholar 

  • McCarthy KE, Woltering EA, Anthony LB (2000) In situ radiotherapy with niIn-pentetreotide. Q J Nucl Med 44:88–95

    PubMed  Google Scholar 

  • Miyake K, Mickley L, Litman T et al (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 59:8–13

    PubMed  Google Scholar 

  • Mochizuki T, Tsukamoto E, Kuge Y et al (2001) FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 42:1551–1555

    PubMed  Google Scholar 

  • Moretti J-L, Cordobes M, Starzec A et al (1998) Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med 39:1214–1218

    PubMed  Google Scholar 

  • Moscow J, Huang H, Carter C et al (1999) Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 94:52–61

    PubMed  Google Scholar 

  • Nagahara H, Vocero-Akbani A, Synder E et al (1998) Transduction of full-length TAT fusion proteins directly into mammalian cells: TAT-p27Kipl induces cell migration. Nat Med 4:1449–1452

    PubMed  Google Scholar 

  • Nagamachi S, Jinnouchi S, Ohnishi T et al (1999) The usefulness of Tc-99m-Tc-MIBI for evaluating brain tumors: comparative study with Tl-201 and relation with P-glycoprotein. Clin Nucl Med 24:765–772

    PubMed  Google Scholar 

  • Newman M, Rodarte J, Benbatoul K et al (2000) Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res 60:2964–2972

    PubMed  Google Scholar 

  • Paganelli G, Zoboli S, Cremonesi M et al (2001) Receptor-mediated radiotherapy with Y-DOTA-D-Phe Tyr’-oc-treotide. Eur J Nucl Med 28:426–434

    PubMed  Google Scholar 

  • Palestro CJ, Bitton R, Tomas MB et al (1997) P829: a technetium-labeled peptide for imaging tumors possessing somatostatin receptors. J Nucl Med 38:236P

    Google Scholar 

  • Pearson DA, Lister-James J, McBride WJ et al (1996) Somatostatin receptor-binding peptides labeled with techne-tium-99m: chemistry and initial biological studies. J Med Chem 39:1361–1371

    PubMed  Google Scholar 

  • Pennisi E (2000) Human genome: finally, the book of life and instructions for navigating it. Science 288:2304–2307

    PubMed  Google Scholar 

  • Piwnica-Worms D (2000) Functional identification of multidrug resistance gene expression in vivo. Am Soc Clin Oncol Educ Book Spring 178–184

    Google Scholar 

  • Piwnica-Worms D, Kronauge J, Chiu M (1990) Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 82:1826–1838

    PubMed  Google Scholar 

  • Piwnica-Worms D, Chiu M, Budding M et al (1993) Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53:977–984

    PubMed  Google Scholar 

  • Piwnica-Worms D, Rao V, Kronauge J et al (1995) Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 34:12210–12220

    PubMed  Google Scholar 

  • Podda S, Ward M, Himelstein A et al (1992) Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676–9680

    PubMed  Google Scholar 

  • Polyakov V, Sharma V, Dahlheimer J et al (1999) Synthesis and characterization in vitro of membrane permeant peptide conjugates for imaging and radiotherapy. J Labelled Compounds Radiopharm 42:S4–S6

    Google Scholar 

  • Polyakov V, Sharma V, Dahlheimer J et al (2000) Novel Tatpeptide chelates for direct transduction of technetium-99m nd rhenium into human cells for imaging and radiotherapy. Bioconjugate Chem 11:762–771

    Google Scholar 

  • Rabindran S, He H, Singh M et al (1998) Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res 58:5850–5858

    PubMed  Google Scholar 

  • Reichlin S (1983 a) Somatostatin, part 1. N Engl J Med 309: 1495–1501

    PubMed  Google Scholar 

  • Reichlin S (1983b) Somatostatin (part 2). New Engl J Med 309:1556–1563

    PubMed  Google Scholar 

  • Reubi JC, Kvols LK, Krenning EP et al (1990) Distribution of somatostatin receptors in normal and tumor tissue. Metabolism [Suppl 2] 39:78–81

    Google Scholar 

  • Rogers BE, McClean SF, Kirkman RL et al (1999) In vivo localization of [lllIn]-DTPA-D-Phel-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res 5:383–393

    PubMed  Google Scholar 

  • Rogers BE, Zinn KR, Buchsbaum DJ (2000) Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q J Nucl Med 44:208–223

    PubMed  Google Scholar 

  • Saito Y, Price R, Rottenberg D et al (1982) Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science 217:1151–1153

    PubMed  Google Scholar 

  • Saito Y, Rubenstein R, Price R et al (1984) Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic assessment in an animal model. Ann Neurol 15:548–558

    PubMed  Google Scholar 

  • Scheper R, Broxterman H, Scheffer G et al (1993) Overex-pression of a Mr 110,000 vesicular protein in non-P-gly-coprotein-mediated multidrug resistance. Cancer Res 53:1475–1479

    PubMed  Google Scholar 

  • Schwarze S, Ho A, Vocero-Akbani A et al (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569–1572

    PubMed  Google Scholar 

  • Shao Y, Cherry S, Farahani K et al (1997) Simultaneous PET and MR imaging. Phys Med Biol 42:1965–1970

    PubMed  Google Scholar 

  • Sharma V, Piwnica-Worms D (1999) Metal complexes for therapy and diagnosis of drug resistance. Chem Rev 99:2545–2560

    PubMed  Google Scholar 

  • Sharma V, Beatty A, Wey S-P et al (2000) Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo. Chem Biol 7:335–343

    PubMed  Google Scholar 

  • Shen DW, Fojo A, Chin JE et al (1986) Human multidrugresistant cell lines: increased mdrl expression can precede gene amplification. Science 232:643–645

    PubMed  Google Scholar 

  • Smith CM, Liu J, Chen T et al (2000) OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy. Digestion 62[Suppl l]:69–72

    PubMed  Google Scholar 

  • Smith T (1998) FDG uptake, tumour characteristics and response to therapy: a review. Nucl Med Commun 19:97–105

    PubMed  Google Scholar 

  • Smith-Jones PM, Stolz B, Bruns C et al (1994) Gallium-67/ Gallium-68-[DFO]-Octreotide—a potential radiopharma-ceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J Nucl Med 35:317–325

    PubMed  Google Scholar 

  • Sorrentino B, Brandt S, Bodine D et al (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99–103

    PubMed  Google Scholar 

  • Stolz B, Smith-Jones PM, Albert R et al (1994) Biological characterization of [67 Ga] or [68 Ga] labelled DFO-octreotide (SDZ-216-927) for PET studies of somatostatin receptor positive tumors. Horm Metab Res 26:452–459

    Google Scholar 

  • Tazebay U, Wapnir I, Levy O et al (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871–878

    PubMed  Google Scholar 

  • Tjuvajev J, Chen S, Joshi A et al (1999) Imaging adenoviralmediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 59:5186–5193

    PubMed  Google Scholar 

  • Torizuka T, Fisher S, Brown R et al (1998) Effect of insulin on uptake of FDG into experimental mammary carcinoma in diabetic rats. Radiology 208:499–504

    PubMed  Google Scholar 

  • Vallabhajosula S, Moyer BR, Lister-James J et al (1996) Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med 37:1016–1022

    PubMed  Google Scholar 

  • Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010–16017

    PubMed  Google Scholar 

  • Vocero-Akbani A, Heyden N, Lissy N et al (1999) Killing HIV-infected cells by transduction with an HIV pro-tease-activated caspase-3 protein. Nature Med 5:29–33

    PubMed  Google Scholar 

  • Wahl R, Hutchins G, Buchsbaum D et al (1991) 18F-2-deoxy-2-fluoro-d-glucose (FDG) uptake into human tumor xenografts: feasibility studies for cancer imaging with PET. Cancer 67:1544–1550

    PubMed  Google Scholar 

  • Wahl R, Henry C, Eithier S (1992) Serum glucose effects on tumor and normal tissue accumulation of 18F-fluoro-2-deoxy-D-glucose (FDG) in rodents with mammary carcinoma. Radiology 183:643–647

    PubMed  Google Scholar 

  • Wahl R, Quint L, Cieslak R et al (1993 a) Anatometabolic tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 34:1190–1197

    PubMed  Google Scholar 

  • Wahl R, Zasadny K, Helvie M et al (1993b) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography (PET): initial evaluation. J Clin Oncol 11:2101–2111

    PubMed  Google Scholar 

  • Warburg O (1931) The metabolism of tumors. Smith, New York, pp 1–129

    Google Scholar 

  • Wester H-J, Brockmann J, Rosch F et al (1997) PET-Phar-macokinetics of 18F-octreotide: a comparison with 67Ga-DFO-and 86Y-DTPA-octreotide. Nucl Med Biol 24:275–286

    PubMed  Google Scholar 

  • Wilson J (1995) Hexokinases. Rev Physiol Biochem Pharmacol 126:65–198

    PubMed  Google Scholar 

  • Wu A, Yazaki P, Tsai S et al (2000) High-resolution micro-PET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci USA 97:8495–8500

    PubMed  Google Scholar 

  • Younes M, Lechago L, Somoano J et al (1996) Wide expression of the human erythrocyte glucose transporter Glut 1 in human cancers. Cancer Res 56:1164–1167

    PubMed  Google Scholar 

  • Yu Y, Annala A, Barrio J et al (2000) Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 6:933–937

    PubMed  Google Scholar 

  • Zasadny K, Helvie M, Hutchins G et al (2000) Monitoring tumor blood flow and volume of distribution during chemohormonotherapy of breast cancer with dedicated PET and 15-0 water. Radiology 217 [Suppl]:219

    Google Scholar 

  • Zeng H, Bain L, Belinsky M et al (1999) Expression of mul-tidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer drugs. Cancer Res 59:5964–5967

    PubMed  Google Scholar 

  • Zinn K, Buchsbaum D, Chaudhuri T et al (2000) Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with Tc-99m or Re-188. J Nucl Med 41:887–895

    PubMed  Google Scholar 

Download references

Authors
  1. David A. Piwnica-Worms
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary D. Luker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carolyn Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard L. Wahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heinrich-Heine-University Düsseldorf, Wannental 45, 88131, Lindau, Germany

    Ludwig E. Feinendegen M.D. (Professor Emeritus Nuclear Medicine) (Professor Emeritus Nuclear Medicine)

  2. Radiology and Medicine SUNY, Stonybrook, USA

    Walton W. Shreeve M.D., Ph.D. (Professor Emeritus) (Professor Emeritus)

  3. Medical Department Brookhaven National Laboratory, Upton, NY, 11973, USA

    Walton W. Shreeve M.D., Ph.D. (Professor Emeritus) (Professor Emeritus)

  4. National Institutes of Health/Clinical Center, Bldg. 10, Rm 1C401 10 Center Drive, MSC 1180, Bethesda, MD, 20892-1180, USA

    William C. Eckelman Ph. D. (Chief PET Department) (Chief PET Department)

  5. Department of Nuclear Medicine, Sung-Ae General Hospital, Shingil-1-Dong, Youngdungpo-Gu, Seoul, 121-200, Korea

    Yong-Whee Bahk M.D., Ph.D. (Professor Emeritus (CUK) and Director) (Professor Emeritus (CUK) and Director)

  6. Nuclear Medicine and Radiation Health Sciences, The Johns Hopkins University School of Hygiene and Public Health, 615 North Wolfe Street, Baltimore, MD, 21205-2179, USA

    Henry N. Wagner Jr. M. D.

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Piwnica-Worms, D.A., Luker, G.D., Anderson, C., Wahl, R.L. (2003). Molecular Imaging in Oncology. In: Feinendegen, L.E., Shreeve, W.W., Eckelman, W.C., Bahk, YW., Wagner, H.N. (eds) Molecular Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55539-8_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55539-8_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62427-8

  • Online ISBN: 978-3-642-55539-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation